ArticleCancer science2024
RETRACTION: Capn4 is a Marker of Poor Clinical Outcomes and Promotes Nasopharyngeal Carcinoma Metastasis via Nuclear Factor-κB-Induced Matrix Metalloproteinase 2 Expression.
Article in Cancer science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionP.-C. Zheng, X. Chen, H.-W. Zhu, W. Zheng, L.-H. Mao, C. Lin, J.-N. Liu and M. Zheng, "Capn4 is a Marker of Poor Clinical Outcomes and Promotes Nasopharyngeal Carcinoma Metastasis via Nuclear Factor-κB-Induced Matrix Metalloproteinase 2 Expression," Cancer Science 105, no. 6 (2014): 630-638, https://doi.org/10.1111/cas.12416. The above article, published online on 07 April 2014 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Masanori Hatakeyama; Japanese Cancer Association; and John Wiley & Sons Australia, Ltd. Following publication, concerns were raised by a third party regarding suspected overlap of elements within the western blot presented in Figure 3b and a figure published earlier in another paper elsewhere. Furthermore, image analysis uncovered several instances of overlap within the cell migration and cell invasion Transwell assay images presented in Figure 3c. The authors were unable to provide the original data and did not provide a satisfactory explanation for the overlaps. As a result, the article's conclusions can no longer be considered valid.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.